CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
the treatment of adults with moderate to severe Atopic Dermatitis (Eczema). OpSCF will be compared to a placebo.OpSCF or placebo will be adm...
Phase 2
Bellevue, Washington, United States and 21 other locations
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...
Phase 2
Seattle, Washington, United States and 26 other locations
The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...
Phase 3
Seattle, Washington, United States and 83 other locations
This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...
Phase 3
Mill Creek, Washington, United States and 100 other locations
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Seattle, Washington, United States and 561 other locations
This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.
Phase 3
Seattle, Washington, United States and 320 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of ado...
Phase 3
Seattle, Washington, United States and 192 other locations
This is a two-part study that will evaluate the safety and efficacy of APG777 in participants with moderate-to-severe Atopic Dermatitis (AD). Part A...
Phase 2
Mill Creek, Washington, United States and 45 other locations
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy treatment.
Phase 3
Mill Creek, Washington, United States of America and 201 other locations
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent parti...
Phase 3
Bellevue, Washington, United States of America and 246 other locations
Clinical trials
Research sites
Resources
Legal